Grant: Idea to Innovation
University of Alberta
$20,000.00
Creating the next generation of glycomaterials for gene and drug delivery applications-Lab2M
EF 2021-22
Résumé
Our plan is to commercialized state-of-the-art functionally modified glycopolymers and glycoconjugates fortheir use as drug/gene delivery vehicles and cell therapies. We have developed unique synthesis approachesthat have allowed the design of new polymeric architectures in high precision with improved binding affinity.Well-defined glycopolymers with varying molecular weights, compositions and architectures have beensynthesized and evaluated their potential as gene/drug delivery vectors and cell scaffolds, allowing faciletailoring with pendant biocompatible moieties with complex structure-activity relationships (acid degradability,redox response, temperature-response). The use of natural polysaccharides for gene delivery has reduced theneed for an excess cationic charge, hence decreasing the system's toxicity, as carbohydrates condensed theoligonucleotides via hydrogen bonding. These carbohydrate units also interact with specific cell receptors(glycans) and serve as targeting agents without a need for further modifications.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
571250-2022
Name nom
Narain, Ravin
Department département
Chemical and Materials Engineering
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2022
Award amount
20000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Installment
inst:1
Partie
1
Nb partie
1
Application title
Creating the next generation of glycomaterials for gene and drug delivery applications-Lab2M
Keyword
NSERC
Application summary
Our plan is to commercialized state-of-the-art functionally modified glycopolymers and glycoconjugates fortheir use as drug/gene delivery vehicles and cell therapies. We have developed unique synthesis approachesthat have allowed the design of new polymeric architectures in high precision with improved binding affinity.Well-defined glycopolymers with varying molecular weights, compositions and architectures have beensynthesized and evaluated their potential as gene/drug delivery vectors and cell scaffolds, allowing faciletailoring with pendant biocompatible moieties with complex structure-activity relationships (acid degradability,redox response, temperature-response). The use of natural polysaccharides for gene delivery has reduced theneed for an excess cationic charge, hence decreasing the system's toxicity, as carbohydrates condensed theoligonucleotides via hydrogen bonding. These carbohydrate units also interact with specific cell receptors(glycans) and serve as targeting agents without a need for further modifications.